Production of Soluble Recombinant Human PH20 Hyaluronidase in CHO Cell Line
Hyaluronidase plays an important role in the temporary degradation of Hyaluronan/ Hyaluronic Acid (HA), a major barrier to bulk fluid movement in the subcutaneous space, thereby enhancing the absorption and bioavailability of co- administered drugs. In this study, a patented soluble recombinant human PH20 (rHuPH20) was used. The patented PH20 sequence has a truncated site at the carboxyl region responsible for membrane anchoring, enabling secretory expression. In our study, structural prediction using AlphaFold and molecular dynamics simulations confirmed the stability of the rHuPH20 enzyme. The gene was cloned into a eukaryotic expression vector (pcDNA3.1(+)) and stably transfected into a CHO-K1 cell line for protein expression. The secreted rHuPH20 was purified through affinity purification. Furthermore, Purified hyaluronidase (rHuPH20) exhibited measurable enzymatic activity of around 100000 IU/ML. These results demonstrated the successful production, purification, and functional activity of soluble rHuPH20. The purpose of this study is to understand the thermostability, cloning, production and efficacy of patented rHuPH20, thereby establishing a benchmark for novel hyaluronidase.